Sharfstein Steps Down as FDA Deputy Commissioner
He will become Maryland's state secretary of health and mental hygiene.
Joshua Sharfstein, MD, the current FDA principal deputy commissioner, is leaving his position to become Maryland state secretary of health and mental hygiene, according to the Wall Street Journal.
Sharfstein held FDA’s second-highest position for just 21 months.
"It was not that I was looking to leave or was burned out," Sharfstein said in an interview cited by the Washington Post. "I was committed to the FDA. But opportunities like this don't come along very often. It's a really great job at a really important moment in time, and with terrific leadership in the state.”
FDA chief Margaret Hamburg, MD, has chosen counselor to the commissioner John Taylor as interim principal deputy commissioner for 60 days until FDA finds a replacement for Sharfstein.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
